BAK · Braskem S.A. · Stock research

Current Thesis

The distress is now fully at the parent and moving through the courts. On 2026-06-26 a São Paulo bankruptcy court granted Braskem a 60-day precautionary injunction (tutela cautelar) freezing financial-creditor enforcement, and the company simultaneously filed Chapter 15 recognition in the Southern District of New York (foreign representative Antonio Reinaldo Rabelo Filho, five affiliates). On 2026-06-30 Fitch cut the global scale to C and S&P placed the issuer in default territory. Its opening term sheet — five-year maturity extension, unsecured status retained, 100% PIK interest through December 2028 — was rejected by creditors demanding shareholder burden-sharing and a Petrobras cash injection that is not expected. The ADR sits near $2.47 (2026-07-23) against a 52-week range of $2.25–$5.40, with the Street's average 12-month target down near $1.50. This is a distressed workout with live equity-impairment risk and no momentum leg to trade.

Bullish and bearish views on Braskem S.A.

The model's bull view on Braskem S.A. (BAK), in brief: 60-day court shield buys runway (2026-06-26). The bear view: Parent is in default per S&P and near-default per Fitch (2026-06-30). Both cases follow in full.

Bull Case

• 60-day court shield buys runway (2026-06-26). The injunction freezes financial-creditor enforcement into roughly late August and pauses forced payment and asset seizure while a consensual deal is negotiated; commercial obligations continue. Equity rallied ~6% into the freeze as near-term forced-payment risk dropped.
• Turnaround owners with equity incentive. IG4 Capital controls ~50.1% of voting capital through the Shine I fund and Petrobras holds ~47% of voting rights; a turnaround PE sponsor plus a strategic co-controller both have reason to fight for residual equity value rather than accept a wipeout.
• Cyclical margin base building. Q1 2026 (reported 2026-05-13) showed recurring EBITDA of ~US$192M, up ~76% QoQ on firmer polyolefin spreads; a 2027 petrochemical up-cycle is the operational upside if the balance sheet is survived.
• Deep optionality if equity is spared. At ~$2.47 and a ~$984M market cap against ~US$9.4B of gross debt, any deal that extends maturities and PIKs coupons without hard dilution would re-rate the option-like common sharply.

Bear Case

• Parent is in default per S&P and near-default per Fitch (2026-06-30). The problem is the consolidated entity, rated at the bottom of the scale, with the court freeze itself read by agencies as a default marker.
• The plan already asks holders to bleed and creditors said no. The rejected term sheet (5-year extension, 100% PIK to Dec-2028, then +200bps) drew demands for shareholder burden-sharing and a Petrobras rescue described as "not expected" — pointing straight at dilution or impairment of the common.
• Liquidity cliff. July debt service runs ~US$549M and Q3 ~US$878M against ~US$800M of June cash; acceleration and cross-default clauses put an estimated ~R$54B (~US$10.4B) at risk, which is why the standstill exists. Net debt/EBITDA sits near 14.7x.
• Street has capitulated. JPMorgan downgraded on restructuring risk and the consensus 12-month target has collapsed to ~$1.50, roughly 37% below the current ADR; the marginal analyst buyer is gone.

Setup & Price Structure

The ADR trades ~$2.47 (2026-07-23), down ~8% on the week and pinned to the lower end of a $2.25–$5.40 52-week range after a multi-leg collapse from above $5. Local BRKM5 is ~R$6.10. Price structure is a broken downtrend printing lower highs and lower lows; the June court-freeze bounce faded, and there is no higher low, no reclaimed moving average, and no volume base to define a momentum entry. For a trend book this is dead tape — a value-trap chart where the low multiple reflects genuine equity-impairment probability, not mispricing. The distress narrative is fully public (rating-agency actions, JPMorgan capitulation, mainstream coverage), so the informational edge is gone and the name reads as a saturated distress story rather than an early accelerating one.

Catalyst Calendar (next 30 days)

• ~2026-08-13 (est.): Q2 2026 results and call; the market read will be liquidity, cash burn and restructuring progress rather than the earnings print.
• another confirmed non-payment event.
• Ongoing / undated: extrajudicial reorganization filing if one-third creditor support is secured, which would trigger a 90-day standstill; a failed negotiation risks a pivot to full judicial reorganization (recuperação judicial). Chapter 15 recognition proceedings advance in the SDNY.
• ~2026-08-25: the 60-day precautionary shield (dated from 2026-06-26) lapses, forcing either a signed deal, a fresh injunction, or escalation — the cleanest dated inflection in the window.

What Would Change Our Mind

A creditor accord that extends maturities and PIKs interest while explicitly sparing the common — paired with a reclaim of ~$3.30 on expanding volume and a confirmed higher low — would convert this from a distressed avoid into an event-driven long worth a small probe. Confirmation of Petrobras or IG4 injecting new equity on terms that protect existing holders would do the same. Absent a signed, equity-friendly deal, any rally should be treated as a bear-market bounce inside an active restructuring.

Correlation Notes

BAK trades as a Brazil-macro and petrochemical-spread proxy: sensitive to BRL/USD, Brazilian rates (Selic) and country risk, and to global polyolefin (PE/PP/PVC) margins driven by naphtha and ethane feedstock and Chinese capacity additions. Petrobras's ~47% voting stake ties the equity to state-oil policy and Brasília politics. Idiosyncratic restructuring headlines now dominate day-to-day; the name will decouple from petrochemical peers (LYB, DOW, WLK) and from broad EM equity beta on any deal or filing print. The Chapter 15 process links it to the US bankruptcy calendar alongside the Brazilian court track.